← Back to headlines
Kerala High Court Seeks Reply on Affordable Cancer Drug Access
The Kerala High Court has sought a reply regarding a writ petition filed in 2022 by a breast cancer patient, who argued that a prescribed patented drug, Ribociclib, was 'too expensive and unavailable at an affordable price.'
17 Jul, 09:28 — 17 Jul, 09:28
